<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=3891153&amp;fmt=gif"/> Client Association for Preventive Health Research
June 08, 2020
3 min reading time

Why set up the Client Association for Preventive Health Research?

In early 2020, the Foundation for Client Advocacy for Preventive Health Research(SCPG) was established.

In mid-2020, a legislative amendment to the Population Screening Act will be debated in the House of Representatives. Among other things, this law regulates the scope for preventive health screening, for which the client himself takes the initiative.

Why this new foundation?

The goal of the Foundation is to ensure that every citizen who chooses to do so can make use of preventive health research. They also believe that everyone has an exclusive right to learn about all research results, without sharing them with third parties.
To achieve this goal, they will provide solicited and unsolicited advice to ministries, patient and consumer associations, medical professionals, and other stakeholders.

To be able to stand up for the interests of people who want to choose such a study, it is important to speak as an organization with a constituency. It is
important to have as large a constituency as possible if they have contact with politics in The Hague.

We can imagine that you would like to be informed about the developments regarding the new Population Screening Act. Since under the Privacy Act (AVG) each organization must collect its own addresses, it is important to report directly to SCPG.

Actions taken by SCPG.

“In March and May of this year, we responded to the draft legislation by sending letters to all parliamentary parties in the House of Representatives.
In the first letter, we emphasized the following:
Citizens have the right to take control of their own health. To that end, they must have the freedom to undergo preventive screenings (for a fee). The results of the screenings must be made available to the client.
The government considers prevention to be important. In this context, the early detection of signs of disease through preventive screening is appropriate.
The government fears that preventive screening will entail high costs for the regular healthcare system due to potential false-positive results. Research shows that this applies to only a few cases. The benefits of early detection of conditions—which allow clients to receive timely treatment—are far greater.
The foundation’s board considers the quality of preventive screening to be important. It is committed to helping establish high standards.
We also believe it is important that the views and wishes of citizens and clients are properly taken into account in the decision-making process.
We have also requested a (virtual) meeting with several parliamentary caucuses.

We recently responded to the questions posed to the State Secretary by the members of the permanent House Committee on Health, Welfare and Sport. The second letter is a brief summary:
We believe, contrary to the opinion of various parliamentary parties, that a result of preventive health screening is in principle unburdening. After all, everyone is happy with a good result and if the result is not so good, one is often diagnosed (very) early and can undergo treatment with less risk. Then you are also happy.
Also, an early detected disease will be much more likely (usually easier) to be treated. That will cost society less than a treatment in a late stage.
We have emphasized again that a client wants and needs to be informed about the complete results of a preventive health examination. Even if unsought for but serious ancillary findings are found. Whether or not one is informed of these ancillary findings must not depend on the possible conscientious objections of the examining doctor".

If you would like to read both letters, they can be found here on the site www.scpg.nl, according to Willem J. van Oort, chairman of the Stichting Cliëntenbelangen Preventief Gezondheidsonderzoek.

Willem J. van Oort is a (bio)chemist, founder and director of a biotech company for the development of anti-cancer and anti-infection drugs.

The bill to amend the Population Screening Act in connection with current developments in the area of preventive medical research was on the agenda of the Lower House before the summer. However, due to the Corona crisis, agenda items have been shifted around a lot. We assume that the discussion will not take place until after the summer. If there are new developments, we will keep you informed.

read here the chamber document of the Council of State

Donation

The board members are happy to do their work and do not get paid for it. But as you will understand, setting up a foundation involves costs. You can think of administrative costs, the cost of the notary, registration with the Chamber of Commerce, developing and maintaining a website, mailings, and so on.

If you like the SCPG foundation and want to donate a small amount of money to cover the costs, we would be very happy with that. You can transfer this to account NL49INGB0008773855 in the name of Stichting Cliëntenbelangen Preventief Gezondheidsonderzoek.

About the Author
Ellen is the founder of Blood Value Testing. She gained her experience with health examinations for companies, schools and government institutions at HumanCapitalCare arbo- en gezondheidsdienst. In 2009 she became director of Diagnostics Netherlands, a collaboration between all major general practitioner laboratories in the Netherlands. At the U- Diagnostics laboratory in Utrecht, she was responsible for blood testing at GPs. Until she founded Blood Values Test for individuals in 2013.
Post comment